Les anti-GPIIb-IIIa = The anti-GPIIb-IIIaNURDEN, P.Transfusion clinique et biologique (Paris). 2001, Vol 8, Num 2, pp 114-122, issn 1246-7820Article

Bidirectional trafficking of membrane glycoproteins following platelet activation in suspensionNURDEN, P.Thrombosis and haemostasis. 1997, Vol 78, Num 5, pp 1305-1315, issn 0340-6245Article

Giant platelets, megakaryocytes and the expression of glycoprotein Ib-IX complexesNURDEN, P; NURDEN, A.Comptes rendus de l'Académie des sciences. Série 3, Sciences de la vie. 1996, Vol 319, Num 8, pp 717-726, issn 0764-4469Article

Analgésie péridurale obstétricale et maladie de Willebrand de type 2B = Epidural labor analgesia and parturient with type 2B von Willebrand diseaseLAGARRIGUE, J; RICHEZ, B; JULLIAC, B et al.Annales françaises d'anesthésie et de réanimation. 2013, Vol 32, Num 1, pp 56-59, issn 0750-7658, 4 p.Article

Le PFA 100 remplacera-t-il le temps de saignement ? = Will the bleeding time be replaced by the PFA 100 ?DENNINGER, M.-H; FRESSINAUD, E; HUISSE, M.-G et al.Hématologie (Montrouge). 2000, Vol 6, Num 1, pp 93-102, issn 1264-7527Article

Ultrastructural analysis of the distribution of the vitronectin receptor (α_Vβ₃) in human platelets and megakaryocytes reveals an intracellular pool and labelling of the α-granule membranePOUJOL, C; NURDEN, A. T; NURDEN, P et al.British journal of haematology. 1997, Vol 96, Num 4, pp 823-835, issn 0007-1048Article

Nature des autoanticorps dans les purpuras thrombopéniques auto-immuns = Autoanticorps in autoimmun thrombopenic purpurasNURDEN, P; CLOFENT-SANCHEZ, G; MACCHI, L et al.Archives de pédiatrie (Paris). 1997, Vol 4, pp 155s-156s, issn 0929-693X, SUP2Conference Paper

Bon usage du danaparoïde sodique : exemple d'une collaboration entre clinicien, biologiste et pharmacien = Good use of danaparoide treatment : a physician, pharmacist and biologist collaboration exampleHADJADJ, C; PAPON, F; BONNIN, M et al.Journal de pharmacie clinique (Paris). 2007, Vol 26, Num 3, pp 166-173, issn 0291-1981, 8 p.Article

Anti-platelet antibodies in patients with systemic lupus erythematosus and the primary antiphospholipid antibody syndrome : Their relationship with the observed thrombocytopeniaMACCHI, L; RISPAL, P; CLOPENT-SANCHEZ, G et al.British journal of haematology. 1997, Vol 98, Num 2, pp 336-341, issn 0007-1048Article

The evolution of megakaryocytes to plateletsNURDEN, P; POUJOL, C; NURDEN, A. T et al.Baillière's clinical haematology. 1997, Vol 10, Num 1, pp 1-27, issn 0950-3536Article

Autoantibodies and anti-mouse antibodies in thrombocytopenic patients as assessed by different MAIPA assaysCLOFENT-SANCHEZ, G; LUCAS, S; LAROCHE-TRAINEAU, J et al.British journal of haematology. 1996, Vol 95, Num 1, pp 153-160, issn 0007-1048Article

The platelet surface expression of glycoprotein V is regulated by two independent mechanisms : proteolysis and a reversible cytoskeletal-mediated redistribution to the surface-connected canalicular systemMICHELSON, A. D; BENOIT, S. E; FURMAN, M. I et al.Blood. 1996, Vol 87, Num 4, pp 1396-1408, issn 0006-4971Article

Des fonctions plaquettaires aux implications thérapeutiques = From platelet functions to therapyJANDROT-PERRUS, M; NURDEN, P.La Revue de médecine interne (Paris). 2010, Vol 31, issn 0248-8663, S319-S323, SUP3Conference Paper

Résistance aux antiagrégants plaquettaires chez le diabétiqueBIDET, A; NURDEN, A; NURDEN, P et al.Archives des maladies du coeur et des vaisseaux. Pratique. 2008, Num 171, pp 29-31, issn 1261-694X, 3 p.Article

Two-way trafficking of membrane glycoproteins on thrombin-activated human platelets : Platelet pathophysiology. INURDEN, P; HEILMANN, E; PAPONNEAU, A et al.Seminars in hematology. 1994, Vol 31, Num 3, pp 240-250, issn 0037-1963Article

Thrombasthenic mice generated by replacement of the integrin α_IIb gene : demonstration that transcriptional activation of this megakaryocytic locus precedes lineage commitmentROUX, D. T.-L; ROULLOT, V; POUJOL, C et al.Blood. 2000, Vol 96, Num 4, pp 1399-1408, issn 0006-4971Article

Three cases of acquired von Willebrand disease associated with systemic lupus erythematosusVIALLARD, J.-F; PELLEGRIN, J. L; VERGNES, C et al.British journal of haematology. 1999, Vol 105, Num 2, pp 532-537, issn 0007-1048Article

Abnormal tyrosine phosphorylation linked to a defective interaction between ADP and its receptor on plateletsLEVY-TOLEDANO, S; MACLOUF, J; ROSA, J.-P et al.Thrombosis and haemostasis. 1998, Vol 80, Num 3, pp 463-468, issn 0340-6245Article

Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disordersCLOFENT-SANCHEZ, G; LAROCHE-TRAINEAU, J; LUCAS, S et al.Human antibodies. 1997, Vol 8, Num 2, pp 50-59, issn 1093-2607Article

A review of the role of platelet membrane glycoproteins in the platelet-vessel wall interactionNURDEN, A. T; NURDEN, P.Baillière's clinical haematology. 1993, Vol 6, Num 3, pp 653-690, issn 0950-3536Article

Applications cliniques actuelles d'une activation plaquettaire par cytométrie en flux = Clinical applications of the detection of activated platelets using flow cytometryNURDEN, P; DURRIEU-JAIS, C; NURDEN, A et al.STV. Sang thrombose vaisseaux. 1997, Vol 9, Num 7, pp 441-448, issn 0999-7385Article

L'intégrine α_IIbβ₃: de la biologie cellulaire aux médicaments antithrombotiques = The integrin α_IIbβ₃: from cellular biology to anti-thrombotic drugsNURDEN, A. T; RUAN, J; NURDEN, P et al.Hématologie (Montrouge). 1997, Vol 3, Num 5, pp 407-415, issn 1264-7527Article

Centre de référence des pathologies plaquettaires = Reference center for platelet diseasesNURDEN, P; DREYFUS, M; FAVIER, R et al.Archives de pédiatrie (Paris). 2007, Vol 14, Num 6, pp 679-682, issn 0929-693X, 4 p.Conference Paper

Diagnostic de la maladie de Glanzmann chez un patient de 66 ans = Glanzmann's thrombastenia diagnosis in a 66 years old patientSTEPANIAN, A; NURDEN, P; BONNET, P et al.Annales de biologie clinique (Paris). 2001, Vol 59, Num 5, pp 660-663, issn 0003-3898Conference Paper

Expression of markers of platelet activation and the interpatient variation in response to abciximabBIHOUR, C; DURRIEU-JAÏS, C; MACCHI, L et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 2, pp 212-219, issn 1079-5642Article